Exagen
Price & Volume
Stats
See more52W Range | $2.67-$12.23 |
Market Cap | $139.8M |
Shares Short | 812,134 |
Financials
See moreRevenue (12 Mos) | $63.5M |
Revenue Growth (YoY) | 37.9% |
Gross Profit (12 Mos) | $38M |
Diluted EPS | -$0.93 |
News
See moreYahoo Finance • 2 months ago
Exagen signals $65M–$70M revenue target for 2025 while advancing new biomarker launches
Yahoo Finance • 3 months ago
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
Yahoo Finance • 5 months ago
[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Yahoo Finance • 5 months ago
Exagen Inc. to Participate in Third Quarter Investor Conferences
About
CEO | Mr. John Aballi |
CFO | Mr. Jeffrey G. Black |
Address | 1261 Liberty Way, Vista, CA, United States, 92081 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Full-Time Employees | 209 |
